Prospective Study
Copyright ©The Author(s) 2015.
World J Gastroenterol. May 7, 2015; 21(17): 5345-5351
Published online May 7, 2015. doi: 10.3748/wjg.v21.i17.5345
Table 1 Clinical characteristic of the study subjects n (%)
VariableValue
Hepatocellular carcinoman = 52
Age (mean ± SD)50.2 ± 17.5
Sex
Male46 (88.5)
Female6 (11.5)
AFP
≥ 200 μg/L32 (61.5)
< 200 μg/L20 (38.5)
HbsAg
Positive52 (100)
Negative0 (0)
Child-Pugh classification
A35 (67.3)
B17 (32.7)
Tumor size cm (mean ± SD)2.0 ± 1.0 (1.0-3.1)
Multiple tumors
Yes10 (19.2)
No42 (80.8)
Tumor location
Liver segment I0 (0)
Liver segment II3 (4.8)
Liver segment III7 (11.3)
Liver segment IV7 (11.3)
Liver segment V9 (14.5)
Liver segment VI11 (17.7)
Liver segment VII12 (19.4)
Liver segment VIII13 (21.0)
Background liver cirrhosis
Present46 (88.5)
Absent6 (11.5)